BRPI0821311A2 - Vetor de expressão em mamíferos - Google Patents

Vetor de expressão em mamíferos

Info

Publication number
BRPI0821311A2
BRPI0821311A2 BRPI0821311-9A2A BRPI0821311A BRPI0821311A2 BR PI0821311 A2 BRPI0821311 A2 BR PI0821311A2 BR PI0821311 A BRPI0821311 A BR PI0821311A BR PI0821311 A2 BRPI0821311 A2 BR PI0821311A2
Authority
BR
Brazil
Prior art keywords
expression vector
mammalian expression
mammalian
vector
expression
Prior art date
Application number
BRPI0821311-9A2A
Other languages
English (en)
Inventor
Hans-Peter Knopf
Burkhard Wilms
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0821311A2 publication Critical patent/BRPI0821311A2/pt
Publication of BRPI0821311B1 publication Critical patent/BRPI0821311B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BRPI0821311A 2007-12-21 2008-12-18 Ácido nucleico de vetor linearizado, método para produção de uma célula hospedeira de mamífero compreendendo o referido ácido, e método para produção de um polipetídeode interesse BRPI0821311B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07150339 2007-12-21
PCT/EP2008/067947 WO2009080720A1 (en) 2007-12-21 2008-12-18 Mammalian expression vector

Publications (2)

Publication Number Publication Date
BRPI0821311A2 true BRPI0821311A2 (pt) 2014-10-14
BRPI0821311B1 BRPI0821311B1 (pt) 2018-09-18

Family

ID=39522442

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821311A BRPI0821311B1 (pt) 2007-12-21 2008-12-18 Ácido nucleico de vetor linearizado, método para produção de uma célula hospedeira de mamífero compreendendo o referido ácido, e método para produção de um polipetídeode interesse

Country Status (16)

Country Link
US (3) US20110045536A1 (pt)
EP (3) EP2227546B1 (pt)
JP (2) JP5701061B2 (pt)
KR (1) KR101657717B1 (pt)
CN (1) CN101903523B (pt)
AU (1) AU2008339985C1 (pt)
BR (1) BRPI0821311B1 (pt)
CA (1) CA2709894C (pt)
DK (1) DK3075858T3 (pt)
ES (2) ES2585502T3 (pt)
IL (1) IL206170A (pt)
LT (1) LT3075858T (pt)
PL (2) PL2227546T3 (pt)
PT (2) PT3075858T (pt)
RU (1) RU2494147C2 (pt)
WO (1) WO2009080720A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101993892A (zh) * 2009-08-31 2011-03-30 长沙赢润生物技术有限公司 肿瘤细胞中靶向性表达shRNA的真核表达载体
KR101868139B1 (ko) * 2010-11-30 2018-06-15 주식회사 엘지화학 새로운 융합 프로모터 및 이를 포함하는 재조합 벡터
WO2013040320A1 (en) * 2011-09-16 2013-03-21 Oregon Health & Science University Methods and kits used in identifying microrna targets
EP2771694A4 (en) 2011-10-26 2015-08-05 Novartis Tiergesundheit Ag MONOCLONAL ANTIBODIES AND METHOD FOR THEIR USE
US9963511B2 (en) * 2011-12-22 2018-05-08 Hoffmann-La Roche Inc. Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides
MX359950B (es) * 2012-11-20 2018-10-17 Novartis Ag Casete de expresión optimizado para expresar un polipéptido con un alto rendimiento.
JP6392245B2 (ja) 2012-12-18 2018-09-19 ノバルティス アーゲー 遺伝子改変哺乳動物細胞における治療用タンパク質の産生
CR20200079A (es) 2012-12-18 2020-03-21 Novartis Ag POLIPÉPTIDOS ESTABILIZADOS DEL FACTOR DE CRECIMIENTO TIPO INSULINA (Divisional 2015-0324)
US20160017319A1 (en) 2013-03-11 2016-01-21 Audrey Nommay Method of screening cell clones
LT3412684T (lt) 2013-07-31 2022-07-11 Novartis Ag Nauji atrankos vektoriai ir eukariotinių ląstelių šeimininkių atrankos metodai
WO2016151599A1 (en) 2015-03-25 2016-09-29 Biogenomics Limited A bigenic mammalian expression vector
UY37758A (es) 2017-06-12 2019-01-31 Novartis Ag Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
KR20220064983A (ko) 2019-09-18 2022-05-19 노파르티스 아게 Nkg2d 융합 단백질 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017478A (en) * 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
EP0555203B1 (en) 1988-12-08 1995-10-18 Abbott Laboratories Expression induction method employing dhfr gene
EP0782615A4 (en) * 1994-09-22 2001-08-22 Merck & Co Inc DNA ENCODING FOR HUMAN PAPILLOMAVIRUS TYPE 6A
US20060246540A1 (en) * 1997-08-26 2006-11-02 Ashkenazi Avi J Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2257303T3 (es) * 1999-07-12 2006-08-01 Genentech, Inc. Vectores de expresion y procedimientos.
EP1228237A1 (en) * 1999-11-01 2002-08-07 Chiron Corporation Expression vectors, transfection systems, and method of use thereof
EP1293564A4 (en) 2000-06-08 2005-08-17 Mitsubishi Pharma Corp EXPRESSION VECTOR FOR SCREENING CELLS HIGH EXPRESSION OF RECOMBINANT PROTEINS, TRANSFORMING HIGH EXPRESSION OF A RECOMBINANT PROTEIN AND USE THEREOF
DE10256083A1 (de) * 2002-11-29 2004-08-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
US7384744B2 (en) * 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
WO2005024015A1 (en) * 2003-09-04 2005-03-17 Medarex, Inc. Expression vector
JP4527010B2 (ja) * 2004-07-20 2010-08-18 日本ブレーキ工業株式会社 ブレーキシューの製造方法
US20060024650A1 (en) 2004-07-30 2006-02-02 Epstein Gerald N Kinesiology-based self-improvement process

Also Published As

Publication number Publication date
EP3075858B1 (en) 2020-01-29
JP5701061B2 (ja) 2015-04-15
IL206170A0 (en) 2010-12-30
JP2011505859A (ja) 2011-03-03
US20110045536A1 (en) 2011-02-24
PT3075858T (pt) 2020-04-30
KR101657717B1 (ko) 2016-09-19
PT2227546T (pt) 2016-08-12
JP2015091238A (ja) 2015-05-14
WO2009080720A1 (en) 2009-07-02
PL2227546T3 (pl) 2016-11-30
LT3075858T (lt) 2020-04-27
EP2227546A1 (en) 2010-09-15
EP2227546B1 (en) 2016-05-04
RU2010129545A (ru) 2012-01-27
CA2709894A1 (en) 2009-07-02
AU2008339985B2 (en) 2012-03-01
ES2585502T3 (es) 2016-10-06
CN101903523B (zh) 2016-05-18
CA2709894C (en) 2017-10-24
US9422574B2 (en) 2016-08-23
EP3075858A1 (en) 2016-10-05
RU2494147C2 (ru) 2013-09-27
KR20100109930A (ko) 2010-10-11
EP3680337A1 (en) 2020-07-15
BRPI0821311B1 (pt) 2018-09-18
US20120271040A1 (en) 2012-10-25
DK3075858T3 (da) 2020-05-04
AU2008339985C1 (en) 2012-12-20
ES2784926T3 (es) 2020-10-02
IL206170A (en) 2016-02-29
CN101903523A (zh) 2010-12-01
USRE49347E1 (en) 2022-12-27
PL3075858T3 (pl) 2020-07-13
AU2008339985A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
BRPI0821311A2 (pt) Vetor de expressão em mamíferos
FR19C1001I2 (fr) Agents de liaison cibles diriges contre b7-h1
BRPI1010873A2 (pt) vetor genético
BRPI0820670A2 (pt) Compensação baseada em inclinação
BRPI0720774A2 (pt) melhoramento de sinal de vetor de campo próximo
BRPI0810202A2 (pt) Derivados de piridina
BRPI0919064A2 (pt) estação de acoplamento com mecanismo de rotação
DK2682093T3 (da) Emballeringssystem
BRPI0821773A2 (pt) Monossebacato derivado de pirazol
BRPI0816040A2 (pt) artigos
FR2924738B1 (fr) Charniere
BRPI0722315A2 (pt) Método de cultura microbiana em larga escala
BRPI1008173A2 (pt) "derivados de piridina espiroindolinona"
PT2274422T (pt) Vetor de expressão
BRPI0914484A2 (pt) Vetor de expressão e processos deste
DK2147106T3 (da) Expressionssystem
PL2367943T3 (pl) Ssaczy wektor ekspresyjny
ITMI20080151U1 (it) Cerniera
ES1066941Y (es) Bisagra de ajuste multidireccional
GB0810154D0 (en) Expression vector
BRPI0909909A2 (pt) caderno de composição
ES1066942Y (es) Bisagra de ajuste multidireccional
FR2921682B1 (fr) Charniere
FI20075944A (fi) Pinnoitusmenetelmä
FI20070190A (fi) Bioreaktori

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/12/2008, OBSERVADAS AS CONDICOES LEGAIS.